{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:26:04Z","timestamp":1777969564893,"version":"3.51.4"},"reference-count":45,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["CPRIT RR220053"],"award-info":[{"award-number":["CPRIT RR220053"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"STX-MSTP NIH training grants","award":["T32GM113896 and T32GM145432"],"award-info":[{"award-number":["T32GM113896 and T32GM145432"]}]},{"name":"Translational Science Training T32 Award","award":["T32TR004545"],"award-info":[{"award-number":["T32TR004545"]}]},{"name":"CPRIT Research Training Award","award":["RP 170345"],"award-info":[{"award-number":["RP 170345"]}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mays Cancer Center at UT Health San Antonio"},{"name":"NIH Shared Instrument","award":["S10-OD030311"],"award-info":[{"award-number":["S10-OD030311"]}]},{"name":"CPRIT Core Facility Award","award":["RP220662"],"award-info":[{"award-number":["RP220662"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Research"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/29947448.2026.2664260","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:45:59Z","timestamp":1777967159000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Murine models for triple-negative breast cancer with differential responsiveness to immunotherapy"],"prefix":"10.1080","volume":"3","author":[{"given":"Thomas J.","family":"Kalantzakos","sequence":"first","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufan","family":"Zhou","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Liu","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Proehl","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Durfee","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Tamayo","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri Alpay","family":"Temiz","sequence":"additional","affiliation":[{"name":"University of Minnesota","place":["Minneapolis, USA"]},{"name":"University of Minnesota","place":["Minneapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Troness","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha","family":"Soni","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita B.","family":"Gupta","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-9112","authenticated-orcid":false,"given":"Reuben S.","family":"Harris","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]},{"name":"University of Texas Health San Antonio","place":["San Antonio, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"Menon G Alkabban FM Ferguson T. Breast cancer. StatPearls Treasure Island (FL) 2024."},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.01.040"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.836417"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-3045"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4147"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11891"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11412"},{"issue":"1","key":"e_1_3_5_9_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41698-024-00722-7","article-title":"A phenocopy signature of TP53 loss predicts response to chemotherapy","volume":"8","author":"Bakhtiar H","year":"2024","unstructured":"Bakhtiar H, Sharifi MN, Helzer KT, et al. A phenocopy signature of TP53 loss predicts response to chemotherapy. NPJ Precis Oncol. 2024;8(1):220.","journal-title":"NPJ Precis Oncol"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45014"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202809"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03249-3"},{"issue":"1","key":"e_1_3_5_14_1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41467-024-45160-y","article-title":"The anti-PD-L1\/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial","volume":"15","author":"Li Q","year":"2024","unstructured":"Li Q, Liu J, Zhang Q, et al. The anti-PD-L1\/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial. Nat Commun. 2024;15(1):1015.","journal-title":"Nat Commun"},{"issue":"2","key":"e_1_3_5_15_1","first-page":"81","article-title":"Inhibition screening data using sarcoma 180 and adenocarcinoma E0771","volume":"15","author":"Goodson LH","year":"1955","unstructured":"Goodson LH, Barvick L, Stone RG, et al. Inhibition screening data using sarcoma 180 and adenocarcinoma E0771. Cancer Res. 1955;15(Suppl. 2):81\u2013102.","journal-title":"Cancer Res"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-2614"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0577"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96582"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3295"},{"issue":"3","key":"e_1_3_5_20_1","first-page":"237","article-title":"Functional and molecular characterisation of EO771.LMB tumours, a new C57BL\/6-mouse-derived model of spontaneously metastatic mammary cancer","volume":"8","author":"Johnstone CN","year":"2015","unstructured":"Johnstone CN, Smith YE, Cao Y, et al. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL\/6-mouse-derived model of spontaneously metastatic mammary cancer. Dis Model Mech. 2015;8(3):237\u2013251.","journal-title":"Dis Model Mech"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.8.6.7689"},{"issue":"6","key":"e_1_3_5_22_1","first-page":"1399","article-title":"Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor","volume":"52","author":"Aslakson CJ","year":"1992","unstructured":"Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992;52(6):1399\u20131405.","journal-title":"Cancer Res"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1410626111"},{"issue":"1","key":"e_1_3_5_24_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s40425-019-0794-7","article-title":"Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery","volume":"7","author":"Taylor MA","year":"2019","unstructured":"Taylor MA, Hughes AM, Walton J, et al. Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery. J Immunother Cancer. 2019;7(1):328.","journal-title":"J Immunother Cancer"},{"issue":"10","key":"e_1_3_5_25_1","article-title":"Inhibition of the PI3\u2005K\/mTOR pathway in breast cancer to enhance response to immune checkpoint inhibitors in breast cancer","volume":"22","author":"Yan C","year":"2021","unstructured":"Yan C, Yang J, Saleh N, et al. Inhibition of the PI3\u2005K\/mTOR pathway in breast cancer to enhance response to immune checkpoint inhibitors in breast cancer. Int J Mol Sci. 2021;22(10.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.5.2851"},{"issue":"1","key":"e_1_3_5_27_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0303-7207(02)00416-1","article-title":"Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice","volume":"200","author":"Zinser GM","year":"2003","unstructured":"Zinser GM, McEleney K, Welsh J. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Mol Cell Endocrinol. 2003;200(1-2):67\u201380.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"e_1_3_5_28_1","first-page":"e100115","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"4","author":"Percie du Sert N","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMJ Open Sci. 2020;4(1):e100115.","journal-title":"BMJ Open Sci"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.8.994"},{"key":"e_1_3_5_30_1","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/sigtrans.2016.30","article-title":"Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer","volume":"1","author":"Gupta HB","year":"2016","unstructured":"Gupta HB, Clark CA, Yuan B, et al. Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer. Signal Transduct Target Ther. 2016;1:16030.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"e_1_3_5_31_1","doi-asserted-by":"crossref","first-page":"101211","DOI":"10.1016\/j.xcrm.2023.101211","article-title":"Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases","volume":"4","author":"Durfee C","year":"2023","unstructured":"Durfee C, Temiz NA, Levin-Klein R, et al. Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases. Cell Rep Med. 2023;4(10):101211.","journal-title":"Cell Rep Med"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0201-4"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.048"},{"issue":"14","key":"e_1_3_5_35_1","doi-asserted-by":"crossref","first-page":"E1301","DOI":"10.1073\/pnas.1210353110","article-title":"Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer","volume":"110","author":"Knight JF","year":"2013","unstructured":"Knight JF, Lesurf R, Zhao H, et al. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proc Natl Acad Sci U S A. 2013;110(14):E1301\u2013E1310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"e_1_3_5_36_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13058-015-0668-y","article-title":"Targeted pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer","volume":"18","author":"Wang S","year":"2016","unstructured":"Wang S, Liu JC, Kim D, et al. Targeted pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer. Breast Cancer Res. 2016;18(1):9.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"e_1_3_5_37_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1095\/biolreprod.116.138370","article-title":"Developmental toxicant exposure is associated with transgenerational adenomyosis in a murine model","volume":"95","author":"Bruner-Tran KL","year":"2016","unstructured":"Bruner-Tran KL, Duleba AJ, Taylor HS, et al. Developmental toxicant exposure is associated with transgenerational adenomyosis in a murine model. Biol Reprod. 2016;95(4):73.","journal-title":"Biol Reprod"},{"issue":"1","key":"e_1_3_5_38_1","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad169","article-title":"Progesterone activates the histone lactylation-Hif1alpha-glycolysis feedback loop to promote decidualization","volume":"165","author":"Zhao W","year":"2023","unstructured":"Zhao W, Wang Y, Liu J, et al. Progesterone activates the histone lactylation-Hif1alpha-glycolysis feedback loop to promote decidualization. Endocrinology. 2023;165(1.","journal-title":"Endocrinology"},{"issue":"1","key":"e_1_3_5_39_1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12876-024-03485-4","article-title":"Epidermal growth factor receptor (EGFR) and SMAD4 negatively correlated in the progression of gallbladder cancer in eastern Indian patients","volume":"24","author":"Choudhury S","year":"2024","unstructured":"Choudhury S, Ghosh S, Chakraborty P, et al. Epidermal growth factor receptor (EGFR) and SMAD4 negatively correlated in the progression of gallbladder cancer in eastern Indian patients. BMC Gastroenterol. 2024;24(1):446.","journal-title":"BMC Gastroenterol"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02978-9"},{"issue":"33","key":"e_1_3_5_41_1","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8\u2005T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin HT","year":"2010","unstructured":"Jin HT, Anderson AC, Tan WG, et al. Cooperation of Tim-3 and PD-1 in CD8\u2005T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 2010;107(33):14733\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100643"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12609-019-00331-5"},{"key":"e_1_3_5_44_1","doi-asserted-by":"crossref","first-page":"1060308","DOI":"10.3389\/fimmu.2023.1060308","article-title":"PD-L1 expression as biomarker of efficacy of PD-1\/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis","volume":"14","author":"Khan M","year":"2023","unstructured":"Khan M, Du K, Ai M, et al. PD-L1 expression as biomarker of efficacy of PD-1\/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis. Front Immunol. 2023;14:1060308.","journal-title":"Front Immunol"},{"issue":"6","key":"e_1_3_5_45_1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007117","article-title":"New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma","volume":"11","author":"Perez-Lanzon M","year":"2023","unstructured":"Perez-Lanzon M, Carbonnier V, Cordier P, et al. New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma. J Immunother Cancer. 2023;11(6.","journal-title":"J Immunother Cancer"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.028"}],"container-title":["Journal of Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/29947448.2026.2664260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:46:05Z","timestamp":1777967165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/29947448.2026.2664260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/29947448.2026.2664260"],"URL":"https:\/\/doi.org\/10.1080\/29947448.2026.2664260","relation":{},"ISSN":["2994-7448"],"issn-type":[{"value":"2994-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ttrr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ttrr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2664260"}}